Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Trichomycosis Pubis : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
References

Related Articles
Chromhidrosis




Patient Education
Click here for patient education.



Author: Vladimir O Osipov, MD, Assistant Professor, Department of Pathology, Section of Bone and Soft Tissue Pathology, Section of Gastrointestinal Pathology, Medical College of Wisconsin

Vladimir O Osipov is a member of the following medical societies: American Medical Association, American Society of Clinical Pathologists, College of American Pathologists, and United States and Canadian Academy of Pathology

Coauthor(s): Scott M Acker, MD, Associate Professor, Director of Dermatopathology, Departments of Dermatology and Pathology, University of Alabama at Birmingham; Peter Langenstroer, MD, Assistant Professor, Department of Surgery, Division of Urology, Medical College of Wisconsin; Milton W Datta, MD, Assistant Professor, Departments of Pathology, Urology, and Hematology-Oncology, Emory University School of Medicine

Editors: Daniel Mark Siegel, MD, MS, Director, Procedural Dermatology Fellowship Program, Clinical Professor of Dermatology, Department of Dermatology, State University of New York Downstate; Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center; Lester F Libow, MD, Dermatopathologist, South Texas Dermatopathology Laboratory; Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania; Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center

Author and Editor Disclosure

Synonyms and related keywords: bacterial infection, hair shaft infection

Background

Trichomycosis is a bacterial infection of the hair shaft found in sweat gland–bearing areas; it has been described most commonly in the axillary region. While initially believed to be uncommon in the inguinal region, a series of papers have described trichomycosis particular to the inguinal area and have suggested that this disease is underestimated in the general population.

Pathophysiology

This discussion of trichomycosis, a disease specific to the hair and sweat gland–bearing regions of the body, concentrates on the involvement of the pubic region in men (trichomycosis pubis). First described in the axillary region by Paxton in 1869, the causative role of multiple bacterial Corynebacterium species was established by Freeman in 1969. Use of the term trichomycosis, and the implied causative role of fungi, has been maintained. The color differences noted at presentation of the condition, their association with particular corynebacteria, or the possible role of associated cocci have not been clarified.

The causative organism associated with most cases is Corynebacterium tenuis, which prefers the moist microenvironment of the inguinal regions. While as many as 33% of adults have colonization by bacteria in the inguinal or axillary regions, factors such as hyperhidrosis initiate more extensive growth and clinical manifestation. The exact origin of the cement substance that creates the grossly visible nodules is debated. Electron microscopy studies favor origin from the causative agents, while others have favored elaboration from apocrine sweat. The actual nidus may be through the modification of apocrine sweat by elaborated cement substance to create the insoluble material that holds bacteria to the hair shaft.

Frequency

United States

Detailed examination of racial, age, or geographic incidence has not been performed, and examinations in the United States are limited to case reports. A more detailed examination (but still limited) has been performed outside the United States.

International

Studies in Panama and the United Arab Emirates revealed rates as high as 39% in patients attending a dermatology clinic. These results correlated with the notably higher incidence in areas of high humidity, warmth, and poor hygiene. The only other study to mention incidence noted the presence of trichomycosis pubis when examining institutionalized mentally retarded patients for trichomycosis axillaris in Edinburgh, Scotland, and noted that of 609 men examined, 16 (2.6%) had pubic disease, of which 3 of the cases (0.5%) were not associated with axillary involvement. Ages of the males affected were 18 and 21 (3 patients) and can be culled only from case reports.

Mortality/Morbidity

Morbidity is low, with most patients unaware of the colonization. When presenting, the most common complaint is a foul odor, and this may continue to cause problems, since trichomycosis often recurs.



History

While many patients are asymptomatic, patients have presented because of pubic rash, foul odor, or growths on the pubic hair. Presenting complaints of colored sweat also have been recorded, resulting in a consideration of chromhidrosis.

Physical

Patients typically present with yellow or red nodules on the hair shafts; yellow is most common. Sweat in the region tends to be colored similarly. Lesions present in the inguinal region, often on the scrotum but occasionally on the base of the shaft of the penis. Lesions can be associated with erythema and itching, and superinfection with dermatophytes has been noted.

Causes

Risk factors appear to be geographic, with the highest incidence in tropic areas. In addition, poor hygiene often is present.

Other diagnostic considerations: Clinical separation from other organisms often is not performed, and treatment focuses on the empirical use of drying agents and topical antibiotics. Thus, the use of topical powders can be a confounding factor in diagnosis. True fungal infections (piedra) also may confound the diagnosis but may be present as superinfection. Piedra presents with nodularity of the hair shafts that is either tan to white (white piedra) or black (black piedra), as opposed to the yellow or red nodules of trichomycosis. White piedra may have a gelatinous appearance.



Chromhidrosis

Other Problems to be Considered

Piedra
Pediculosis pubis
Hair casts (peripilar casts, pseudonits)



Lab Studies

  • Hair culture can be used to grow the anaerobic diphtheroids present as short gram-positive rods. These studies usually are not essential but may be used if no response to initial treatment occurs or targeted antibacterial treatment fails to result in a cure (and fungal superinfection should be eliminated).

Histologic Findings

While usually not performed, in rare cases samples of the hair have been removed and sent for surgical pathology slide preparation. These cases document the presence of filamentous bacterial growth perpendicular to the hair shaft, present in a background of elaborated cement substance that makes up the concretions. The bacteria adhere to but do not penetrate the hair shaft. Superinfection with cocci or fungi also can be present.



Medical Care

Treatment involves alleviating the hyperhidrosis through the use of drying agents. Topical clindamycin is helpful in refractory or extensive cases. Additional recommended agents include naftifine hydrochloride cream (1%), which has been used for its combined antifungal and antibacterial actions.



The goals of pharmacotherapy are to reduce morbidity and to prevent complications.

Drug Category: Antifungals

Mechanism of action usually involves inhibiting pathways (enzymes, substrates, transport) necessary for sterol/cell membrane synthesis or altering the permeability of the cell membrane (polyenes) of the fungal cell.

Drug NameNaftifine (Naftin)
DescriptionSynthetic allylamine derivative shown to exhibit fungicidal activity in vitro against a broad spectrum of organisms including species of Trichophyton, Microsporum, and Epidermophyton genera. Has shown fungistatic activity against Candida species. Exact mechanism of action is not known; however, appears to interfere with sterol biosynthesis by inhibiting squalene 2,3-epoxidase. Treatment should continue up to 4 wk. If no improvement is noted, re-evaluate patient.
Adult DoseGently massage (1% cream/gel) sparingly into affected area and surrounding skin qd up to 4 wk
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsNone reported
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsFor topical use only; not for ophthalmic use

Drug Category: Antimicrobials

Empiric antimicrobial therapy must be comprehensive and should cover all likely pathogens in the context of the clinical setting. Antibiotic selection should be guided by blood culture sensitivity whenever feasible.

Drug NameClindamycin solution (Cleocin T, Clinda-Derm)
DescriptionWide-spectrum antibiotic effective in vivo against various microbial organisms including Corynebacterium species. Antibiotic binds preferentially to the 50S ribosomal subunit affecting the process of peptide chain initiation in bacteria.
Adult DoseApply to affected area bid
Pediatric Dose<12 years: Not established
>12 years: Apply as in adults
ContraindicationsDocumented hypersensitivity; history of antibiotic-associated colitis
InteractionsHas neuromuscular blocking properties that may enhance action of other neuromuscular blocking agents
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsUse of topical formulation results in absorption of antibiotic from skin surface; diarrhea and colitis (including pseudomembranous colitis) have been reported with use of topical and systemic clindamycin; discontinue if significant diarrhea occurs

Drug NameBenzoyl peroxide (Benoxyl, Fostex, Benzac)
DescriptionFree-radical oxygen is released upon administration and oxidizes bacterial proteins in sebaceous follicles, decreasing the number of anaerobic bacterial and irritating free fatty acids. Has keratolytic and comedolytic effects.
Use gel, pads, or wash.
Adult DoseApply sufficient quantity to affected and surrounding skin areas bid qam and qpm; reduce dose, frequency, or concentration if excessive dryness or peeling occurs
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsPotentiates adverse effects of tretinoin
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsAvoid contact with lips, eyelids, mucous membranes, and eyes; for external use only; discontinue if swelling, burning, or excessive dryness occurs

Drug Category: Astringents

Agents that work to dry up the sweat glands.

Drug NameAluminum chloride (Xerac-AC roll-on, Certain-dry pads, Drysol solution)
DescriptionAstringent agent used in management of hyperhidrosis.
Adult DoseApply to affected area hs; to prevent irritation, completely dry area prior to application
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsNone reported
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsNot for application on irritated, broken, or recently shaved skin; for external use only



Deterrence/Prevention:

  • Since studies show notably higher incidence in regions of the world with high humidity and temperatures and in people with poor hygiene, emphasize measures aimed at maintaining dry skin and proper hygiene.

Complications:

  • The primary complication appears in individuals who are immunocompromised and can develop septicemia secondary to colonization of catheters and surgical sites. Infection in hosts who are immunocompetent yields few long-term adverse effects.
  • Recurrence is common, but the simplicity of treatment and improved hygiene make follow-up care simple.
  • In rare cases, shaving the pubic hair after treatment has been advocated to prevent recurrences, although this was met with patient resistance.

Prognosis:

  • Aside from the risk of recurrence, prognosis is excellent, and treatment is effective.

Patient Education:

  • Instruct patients to keep skin dry and to practice proper hygiene.



Medical/Legal Pitfalls

  • Since most people with trichomycosis pubis do not seek clinical care, medical pitfalls do not exist. Patients who seek care have fulminant disease and desire treatment.

Special Concerns

  • Consider examination and treatment of sexual partners, although to date, no studies have compared the incidence of trichomycosis pubis in sexual partners.



  • Bargman H. Trichomycosis of the scrotal hair. Arch Dermatol. Mar 1984;120(3):299. [Medline].
  • Crissey JT, Rebell GC, Laskas JJ. Studies on the causative organism of trichomycosis axillaris. J Invest Dermatol. May 1952;19(3):187-97. [Medline].
  • Freeman RG, McBride ME, Knox JM. Pathogenesis of trichomycosis axillaris. Arch Dermatol. Jul 1969;100(1):90-5. [Medline].
  • Lestringant GG, Qayed KI, Fletcher S. Is the incidence of trichomycosis of genital hair underestimated?. J Am Acad Dermatol. Feb 1991;24(2 Pt 1):297-8. [Medline].
  • McBride ME, Freeman RG, Knox JM. The bacteriology of trichomycosis axillaris. Br J Dermatol. Aug 1968;80(8):509-13. [Medline].
  • Montes LF, Vasquez C, Cataldi MS. Electron microscopic study of infected hairs in trichomycosis axillaris. J Invest Dermatol. 1963;40:273-8.
  • Noble WC, Savin JA. Trichomycosis of the scrotal hair. Arch Dermatol. Jan 1985;121(1):25. [Medline].
  • O'Dell ML. Skin and wound infections: an overview. Am Fam Physician. May 1998;15;57(10):2424-32. [Medline][Full Text].
  • Paxton FV. On a disease condition of the hairs of the axilla, probably of parasitic origin. J Cutan Med. 1869;3:133.
  • Rosen T, Krawczynska AM, McBride ME, Ellner K. Naftifine treatment of trichomycosis pubis. Int J Dermatol. Sep 1991;30(9):667-9. [Medline].
  • Savin JA, Somerville A, Noble WC. The bacterial flora of trichomycosis axillaris. J Med Microbiol. May 1970;3(2):352-6. [Medline].
  • White SW, Smith J. Trichomycosis pubis. Arch Dermatol. Apr 1979;115(4):444-5. [Medline].
  • Zaias N, Taplin D, Rebell GS. Final Report, Republic of Panama Medical Research. Washington, DC:. Walter Reed Army Institute of Research;1964.

Trichomycosis Pubis excerpt

Article Last Updated: Feb 1, 2007